Adipose-Derived Stromal Cells (ASC's) for Pressure Ulcers

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pressure Ulcer
Interventions
BIOLOGICAL

Adipose-derived stromal cells

Adipose-derived stromal cells contain stem cells which have been successful in enhancing wound healing. The product used as the carrier is a fibrin sealant called TISSEEL. Pre-pilot testing was done to verify viability of the stromal cells for up to 72 hours in the fibrin sealant.

DRUG

Adipose-derived stromal cells

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER